MedTrace Logo

Proper Fractional Flow Reserve Criteria for Intermediate Lesions in the Era of Drug-eluting Stent

NCT00592228 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2010-12-21

No results posted yet for this study

Summary

Angiographic evaluation for intermediate lesions is not always accurate. Fractional flow reserve-guided deferral strategy for these lesions showed the same event rate as routine intervention strategy. However, proper FFR criterion for these lesions in the era of drug-eluting stent is not known. This study sought to evaluate the clinical outcomes of intermediate lesions according to FFR and compare those of FFR-guided intervention with routine drug-eluting stent implantation strategy.

Conditions

  • Coronary Angiography
  • Drug-eluting Stents
  • Fractional Flow Reserve, Myocardial

Interventions

DEVICE

Cypher, Taxus or Endeavor

percutaneous drug-eluting stent implantation, 1. FFR group: if FFR\<0.75 2. Routine DES group

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Bon-Kwon Koo · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592228 on ClinicalTrials.gov